Winton Matthew, Chief Commercial and Business Officer at CervoMed Inc. ($CRVO), made three open market purchases totaling about $117 thousand over the past year. His most recent buy was on November 18, 2025. These purchases rank him 2010th among nearly 5,000 insiders, where the average buy is around $1.5 million across 3.3 transactions. He reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | CervoMed Inc. | $CRVO | Winton Matthew | Chief Commercial and Business | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 9,252,719 | 9999.99% | 0.32% |
| Nov. 17, 2025 | CervoMed Inc. | $CRVO | Winton Matthew | Chief Commercial and Business | P | Common Stock | 3500 | $8.43 | 13,500.0000 | 9,252,719 | 35.00% | 0.04% |
| Nov. 18, 2025 | CervoMed Inc. | $CRVO | Winton Matthew | Chief Commercial and Business | P | Common Stock | 1500 | $7.95 | 15,000.0000 | 9,252,719 | 11.11% | 0.02% |
| Nov. 14, 2025 | CervoMed Inc. | $CRVO | Winton Matthew | Chief Commercial and Business | P | Common Stock | 10000 | $7.57 | 10,000.0000 | 9,252,719 | 9999.99% | 0.11% |
| Oct. 6, 2025 | CervoMed Inc. | $CRVO | Winton Matthew | Chief Commercial and Business | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,702,719 | 9999.99% | 0.86% |